To further narrow down the list of plasma miRNAs as TB biomarkers, we applied the criteria for including plasma miRNAs as follows: for CP-TB and NCP-TB patients compared with healthy controls, sequencing reads should be larger than 500 and there should be at least a 4-fold difference in miRNA expression between the comparative groups. The gene discussed is CP; the disease is tuberculosis.